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Castleman disease of the spine mimicking a nerve sheath 
tumor
Case report
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S Castleman disease is a rare lymphoproliferative disease of unknown cause. In most cases, afflicted patients present 
with a mediastinal mass although the disease may manifest in numerous other sites, including intracranially and rarely 
intraspinally. The authors report on the case of a 19-year-old woman who presented with a large paraspinal mass ema­
nating from the T7-8 neural foramen. The morphological and signal characteristics revealed on magnetic resonance 
imaging were similar to those of nerve sheath tumors. The patient underwent open biopsy sampling of the lesion, and 
results of a pathological evaluation revealed hyaline-vascular type Castleman disease. She underwent radiotherapy and 
remains symptom-free with a radiographically stable lesion 1 year later. Although the disease has been reported to 
mimic a meningioma when encountered in intracranial locations, to the authors’ knowledge, this is the first case of the 
disorder mimicking a nerve sheath tumor. When the diagnosis of Castleman disease is made, good results can be 
obtained with partial resection and radiotherapy.
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a s t l e m a n  disease is a rare lymphoproliferative con- 
f  dition of unknown cause that was first characterized 
V - x  by Castleman and colleagues in 1956;’ numerous 
cases have been described since. Although the disease is 
usually manifested as an isolated mass in the mediastinum, 
it can appear in diverse locations—most commonly the 
abdomen, neck, and axillae— or it may have a multifocal 
presentation with predominantly systemic symptoms.2-1-5-16-
17.19.21.22 Along with its broad array of clinical presentations, 
the nomenclature for this abnormality has been wide rang­
ing, with the condition being variably termed angiofollicu- 
lar hyperplasia, localized nodal hyperplasia, giant lymph 
node hyperplasia, angiomatous lymphoid hamartoma, fol­
licular lymphoreticuloma, and benign giant lymphoma.
The disease has two primary histological subtypes, the 
hyaline-vascular type and the plasma cell type. The hya­
line-vascular type accounts for approximately 85 to 90% of 
all cases and is typically manifested by a localized lesion.17-
20.22 The plasma cell type occurs in approximately 5 to 10% 
of cases and is most often a generalized or multifocal dis­
ease. I7-22-26 There is also a mixed variant, with the histologi­
cal characteristics of both primary subtypes, comprising the 
remaining cases.17
Central nervous system involvement in Castleman dis­
ease is exceedingly rare. To our knowledge, only 13 cases
Abbreviations used in this paper: CNS = central nervous system; 
MR = magnetic resonance.
of intracranial Castleman disease have been reported in the 
literature.4-5-"-1-5-18-21-27-51-5-5 When there is CNS involvement, 
the disease typically manifests as a dura mater-based lesion 
mimicking a meningioma. Patients often present with 
symptoms referable to the lesion location and are treated 
effectively with surgical excision. Castleman disease of the 
spine is a more rare entity, with only four previously report­
ed cases.1-6-16-19 The patients with Castleman disease of the 
spine presented with myelopathic symptoms secondary to 
epidural disease in each case. All were treated effectively 
with surgical excision, which was complete in three of the 
four patients, and there were no signs of recurrence in the 
limited follow-up data provided.
We present a case of Castleman disease that manifested 
as a paraspinal mass extending through the neural foramen 
into the thoracic spine and mimicking a nerve sheath tumor. 
To our knowledge this is the first such case in the literature.
Case R eport
Histoiy and Examination. This 19-year-old woman with 
no significant medical or surgical history was treated by her 
primary care provider for cough and intermittent nausea 
and vomiting of 3-weeks’ duration. She received a diag­
nosis of bronchitis but presented to our institution when her 
symptoms did not resolve after a course of antibiotic med­
ication. Chest radiographs were obtained and revealed 
a large right paraspinal mass (Fig. 1). On MR imaging a 
6.2 X 6.8 X 6.1-cm heterogeneously enhancing mass was
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F ig .  I. Anteroposterior (left) and lateral (right) chest radiographs demonstrating a large paraspinal mass on the right.
noted in the right paraspinal region, extending into the right 
T7-8 neural foramen (Fig. 2). The mass was isointense rel­
ative to the spinal cord on T,-weighted imaging and slight­
ly hyperintense on T,-weighted sequences. The neural fora­
men was not expanded. Schwannoma was considered the 
most likely diagnosis.
Operation and Pathological Findings. A right thoracoto­
my was performed in anticipation of complete resection. 
The tumor appeared fleshy and bled profusely when man­
ipulated (Fig. 3). After a frozen section of a tissue sample 
obtained from the lesion revealed lymphoid tissue consis­
tent with lymphoma, attempts at radical resection were 
aborted. Results of the final pathological examination 
revealed areas of focal sclerosis and dense lymphoid infil­
trate with numerous lymphoid follicles (Fig. 4). Some of 
these follicles had small germinal centers and were sur­
rounded by thickened mantle zones of small round lym­
phoid cells, some of which were arranged in onion bulb­
shaped whorls. Occasional sclerotic blood vessels were 
noted to penetrate through the mantle zones. One follicle 
fragment was composed of small monomorphic round lym­
phocytes through which there ran numerous small hyalin- 
ized blood vessels and larger vascular structures with thick 
vessel walls. The results of flow cytometry revealed a mix 
of B and T cells with no evidence of monoclonality, leuke­
mia, or non-Hodgkin lymphoma. The final diagnosis was 
hyaline-vascular type Castleman disease.
Postoperative Course. The patient recovered without 
complications and underwent radiotherapy (total dose 3960 
cGy given in 22 fractions). She has tolerated this regime 
well and is currently asymptomatic with no evidence of 
lesion progression observed on radiographs obtained 1 year 
postoperatively.
Discussion
Castleman disease can present with either unicentric or
F ig .  2. Gadolinium-enhanced T,-weighted coronal (upper) and 
axial (lower) MR images demonstrating a large heterogenously 
enhancing mass extending from the neural foramen.
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Fig. 3. Intraoperative photograph showing a large fleshy tumor 
in the thoracotomy defect.
multicentric type disease. Although the unicentric variety is 
most often of the hyaline-vascular subtype and the multi­
centric variety is mostly of the plasma cell variety, any 
combination may be present. The plasma cell variant is 
considered to be the most active and aggressive form of the 
illness; some authors have postulated that the hyaline-vas­
cular subtype represents an end stage of the plasma cell 
type of disease.2-17
The cause of Castleman disease is unknown, although 
numerous hypotheses have been put forth including infec­
tious,17 hamartomatous,15 inflammatory,1"* and autoim­
mune8 processes. Interestingly, an increased risk of non- 
Hodgkin lymphoma and Kaposi sarcoma has been reported 
in patients with Castleman disease and mandates vigilant 
surveillance.1-" A thorough search for concurrent malig­
nancies and attentive observation for future malignancies is 
thus warranted.
The most common form of Castleman disease is unicen­
tric. Although it has a propensity to occur in the mediasti­
num it also commonly affects a variety of nodal and extra- 
nodal tissue in the abdomen, pelvis, neck, and axilla, and is 
most often asymptomatic and discovered incidentally.--'-173 
More rarely, and especially if the lesion has the histological 
characteristics of plasma cells, patients with unicentric 
Castleman disease may present with systemic symptoms 
and laboratory abnormalities including fever, weight loss, 
anemia, elevated erythrocyte sedimentation rate, and hy­
pergammaglobulinemia.2-'-17-22 Treatment is largely centered 
on resection. Radical excision has been curative in most re­
ports, although there have been reports of lesion recur­
rences up to 11 years postoperatively.2-17-24-'2 The use of par­
tial resection or observation only have also been reported, 
with only rare progression noted.2-17 Radiotherapy has been 
advocated but its use is controversial; some authors have 
reported a good or even complete response to treatment, 
and others have reported no response.2-17-'u-'4 Results of ra­
diotherapy may be more favorable in patients with the plas­
ma cell variant of the disease.2
Multicentric Castleman disease tends to affect an older 
population than does unilateral Castleman disease, and it is 
more often associated with systemic symptoms, abnormal­
ities on laboratory tests, and abnormal examination find­
ings including hepatosplenomegaly, adenopathy, and mo-
Fig. 4. Photomicrographs. Upper: Dense lymphoid infiltrate 
with lymphoid follicles, germinal centers, and onion bulb-shaped 
whorls are seen. Lower: Hyalinized blood vessel is demonstrat­
ed. H & E. Original magnifications X  10 f upper) and X  40 f lower).
tor-sensory neuropathy, with the latter portending a worse
prognosis 2,7,173,26,28 Median survival durations as short as
26 months have been reported in the multicentric Castle­
man disease group, whereas patients with the hyaline-vas­
cular variant may follow a more benign course and have 
better long-term survival rates.2-*5 In either case, the clinical 
course may be variable. When the disease progresses rapid­
ly, death usually results from sepsis.''-17-*5 Surgical treatment 
for the multicentric disease is limited to biopsy sampling 
and debulking of a large mass only when symptoms are 
provoked.'' Definitive therapy for patients with Castleman 
disease relies on radiotherapy and chemotherapy, which 
have had mixed results.2-"'-14-17-25-26
Castleman disease is a diagnosis of exclusion, declared 
only after careful consideration of the more common caus­
es of lymphadenopathy.22 Imaging is certainly a useful ad­
junct in the workup of the illness; however definitive pre­
operative diagnosis is not possible on imaging because the 
lesions display considerable variance in MR imaging signal 
characteristics.1-6-21 The diagnosis therefore depends on a 
combination of clinical, imaging, and histological data.
Castleman disease of the CNS is a rarely described enti­
ty. The 13 reported cases of intracranial Castleman disease 
have been summarized by Matsumura et al.21 Patients with 
the disease often present with seizures or focal neurologi-
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cal signs, and on MR imaging an enhancing dura mater- 
based mass similar to a meningioma is revealed. A signifi­
cant amount of perilesional edema out of proportion with 
what would normally be expected for the lesion's size is 
often present. Nine of the reported patients had the hyaline- 
vascular variant of the lesion, two had the plasma cell type, 
and two had a mixed type. All patients underwent surgery, 
which resulted in gross-total resection in all but two cases. 
The two patients who underwent partial resection and 
one of the patients who underwent gross-total resection re­
ceived radiotherapy. There have been no reports of recur­
rence with follow-up monitoring reported for up to 8 years.
Spinal Castleman disease has been reported four times to 
occur as an extradural lesion in the cervical and thoracic re­
gion.1'61619 All patients in these studies presented with signs 
of myelopathy. Three patients were treated with laminecto­
my and complete excision, and one patient underwent only 
partial excision. Three patients had hyaline-vascular type 
lesions and one had the plasma-cell variant. Follow up has 
been limited in these cases, but no lesion recurrence has 
been reported.
The case in the present study is unique in that the imag­
ing characteristics of the mass were similar to those of a 
schwannoma. Schwannomas of the spine often originate in 
the spinal canal and can extend through the neural foramen 
into the paraspinal space. Most schwannomas enhance 
sharply on MR imaging after Gd administration, and fre­
quently demonstrate iso- to hypointense signal characteris­
tics on T,-weighted images and hyperintense signal charac­
teristics on T:-weighted imaging sequences. Tlie lesion in 
our patient enhanced on T,- and Tr weighted imaging with 
signal characteristics consistent with a spinal schwannoma. 
Spinal schwannomas may also cause bone abnormalities in 
the adjacent structures, including narrowing of the pedicle, 
enlargement of the intervertebral foramen, and scalloping 
of the vertebral body.’9 Our patient's bones remained nor­
mal, but osseous damage is not a universal finding in 
patients with schwannomas. The imaging characteristics in 
our patient were thus consistent with the more common 
diagnosis of schwannoma.
Our patient presented with symptoms suggestive of 
bronchitis, which were probably unrelated to the tumor's 
location. Although only partial resection was undertaken in 
our patient, her symptoms resolved postoperatively. She 
has tolerated radiotherapy well and has shown no sign of 
tumor progression or symptom recurrence in 1 year of fol­
low-up monitoring. We plan further follow up with bian­
nual imaging studies and will consider reexploration and 
surgical debulking if any evidence of progression is dem­
onstrated.
In summary, Castleman disease is a rare lymphoprolifer­
ative disorder that rarely affects the CNS. We report on an 
unusual case in which the lesion mimicked a nerve sheath 
tumor. The lesion in this patient remains stable after an 
open excisional biopsy procedure and radiotherapy.
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